Traveling for Care?
Whether you're crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.
The Johns Hopkins Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Program was formed in order to provide specialized evaluation and care for patients with ARVD / ARVC. The program, headed by Dr. Hugh Calkins, also focuses on clinical and genetic research. Since 1999, patients with ARVD / ARVC have come to Johns Hopkins, receiving care from leading experts in the field of ARVD / ARVC.
The Johns Hopkins Arrhythmogenic Right Ventricular Dysplasia / Cardiomyopathy (ARVD / ARVC) program has three objectives:
For more information on the Johns Hopkins Right Ventriular Dysplasia/Cardiomyopathy Program, please contact us to request a brochure or other information.